PRESS RELEASE published on 06/27/2024 at 07:30, 2 years 1 month ago APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the Management Board with a view to the strategic development of the Company APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the Management Board to enhance strategic development, internationalization, and ESG strategy. CFO brings strong financial expertise CFO Strategic Development Management Board APONTIS PHARMA AG Thomas Zimmermann
PRESS RELEASE published on 06/27/2024 at 07:30, 2 years 1 month ago Nordex Group to restart production in its manufacturing facility in Iowa, US Nordex Group announces the restart of production at its Iowa manufacturing facility, expanding local footprint for North America growth strategy North America Manufacturing Facility Nordex Group Iowa Production Restart
PRESS RELEASE published on 06/27/2024 at 07:30, 2 years 1 month ago WE ACCESS : Résultat de l'Augmentation de Capital WEACCESS annonce le succès de l'augmentation de capital. SCI INFOSAT renforce sa participation à hauteur de 39.59% du capital et des droits de vote de la Société Augmentation De Capital Participation WEACCESS SCI INFOSAT Réseaux Haut Débit
PRESS RELEASE published on 06/27/2024 at 07:30, 2 years 1 month ago Inside Information / Other news releases Sensorion appoints Laurene Danon as Chief Financial Officer, bringing 15 years of experience in investment banking. The company focuses on developing therapies for hearing loss disorders Chief Financial Officer Investment Banking Sensorion Laurene Danon Hearing Loss Therapies
PRESS RELEASE published on 06/27/2024 at 07:30, 2 years 1 month ago Informations privilégiées / Autres communiqués Sensorion annonce la nomination de Laurène Danon en tant que Directrice Financière. Mme Danon apporte plus de 15 ans d'expérience en finance. La société se concentre sur le développement de nouvelles thérapies pour les troubles de l'audition Biotechnologie Directrice Financière Sensorion Thérapies Auditives Laurene Danon
PRESS RELEASE published on 06/27/2024 at 07:15, 2 years 1 month ago MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2023 DNXcorp annonce la mise à disposition de son rapport financier annuel 2023. Consultez-le sur www.dnxcorp.com. Prochaine publication : Chiffre d'Affaires et Résultats semestriels S1 2024 le 25 septembre 2024 Chiffre D'affaires Résultats Semestriels Rapport Financier Annuel Site Internet DNXcorp
REGULATED PRESS RELEASE published on 06/27/2024 at 07:00, 2 years 1 month ago OVHcloud - Communiqué de presse du chiffre d'affaires du T3 FY2024 Croissance de 10,1 % du chiffre d'affaires au T3 FY2024 chez OVHcloud. Objectifs confirmés pour FY24. Nouveaux GPUs NVIDIA et modèles IA intégrés. Expansion internationale et offre Souveraine Chiffre D'affaires Croissance OVHcloud Objectifs Annuels NVIDIA
REGULATED PRESS RELEASE published on 06/27/2024 at 07:00, 2 years 1 month ago OVHcloud - Q3 FY2024 Revenue Press Release OVHcloud reports 10.1% revenue growth in Q3 FY2024, reaffirms annual targets and medium-term outlook. Strong growth in cloud segments and international expansion OVHcloud Revenue Growth Cloud Services International Expansion Q3 FY2024
PRESS RELEASE published on 06/27/2024 at 07:00, 2 years 1 month ago Des pourboires moins élevés: l’inflation freine la générosité Étude de la Banque Cler montrant une baisse des pourboires en Suisse à cause de l'inflation. Impact positif de la qualité du service sur la générosité. Pratique du pourboire et paiement numérique examinés Suisse Inflation Banque Cler Pourboires Service
PRESS RELEASE published on 06/27/2024 at 07:00, 2 years 1 month ago SCHOTT Pharma continues growth path in the second quarter of fiscal year 2024 SCHOTT Pharma reports 11% revenue growth in Q2 2024, reaffirms guidance for fiscal year. Focus on high-value solutions and expansion. Key figures and strategic developments outlined Financial Results Expansion Revenue Growth SCHOTT Pharma High-value Solutions
Published on 08/27/2026 at 00:05, 16 minutes ago Kidoz Reports Record Q2 2026 Revenue, up 37%, as H1 Revenue Reaches US$6.28 Million (CAD$8.66 Million)
Published on 08/26/2026 at 23:00, 1 hour 21 minutes ago Datametrex Announces Transition to Semi-Annual Financial Reporting
Published on 08/26/2026 at 22:30, 1 hour 51 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 08/26/2026 at 22:30, 1 hour 51 minutes ago Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement
Published on 08/26/2026 at 21:15, 3 hours 6 minutes ago Announces Private Placement of Convertible Promissory Notes
Published on 08/26/2026 at 23:05, 1 hour 16 minutes ago Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
Published on 08/26/2026 at 18:44, 5 hours 37 minutes ago AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results
Published on 08/26/2026 at 18:40, 5 hours 41 minutes ago MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM
Published on 08/26/2026 at 18:30, 5 hours 51 minutes ago Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Published on 08/26/2026 at 18:00, 6 hours 21 minutes ago MHM Corporate: reduces the nominal value of its shares to €0.011
Published on 08/26/2026 at 18:02, 6 hours 19 minutes ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:02, 6 hours 19 minutes ago Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial
Published on 08/26/2026 at 18:00, 6 hours 21 minutes ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/26/2026 at 18:00, 6 hours 21 minutes ago Altarea : Conclusion d’un accord global mettant fin au litige entre Altarea et les actionnaires du groupe Praemia (ex-groupe Primonial)
Published on 08/26/2026 at 18:00, 6 hours 21 minutes ago KLARSEN : lance Dimea, sa nouvelle activité e-commerce dédiée aux compléments alimentaires